Martin P Carroll MD
Associate Professor, Medicine, Perelman School of Medicine
Join to view full profile
3400 Spruce St"# 15"Philadelphia, PA 19104
Phone+1 215-662-3914
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Martin Carroll, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is an Associate Professor at Perelman School of Medicine.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1997
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
Geisel School of Medicine at DartmouthClass of 1988
Certifications & Licensure
PA State Medical License 1998 - 2026
Publications & Presentations
PubMed
- 11 citationsPersistent postremission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia.Ryan D Chow, Priya Velu, Safoora Deihimi, Jonathan Belman, Angela Youn
Blood Advances. 2025-04-22 - 4 citationsTumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.Margaret Rowe, Daria Babushok, Martin Carroll, Alison Carulli, Noelle Frey
European Journal of Haematology. 2025-04-01 - 8 citationsAcquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia.Fiona C Brown, Xin Wang, Richard Birkinshaw, Chong Chyn Chua, Thomas Morley
Blood Advances. 2025-01-14
Press Mentions
Genomic Features of AML in Patients over Age 60 Can Predict Success of Bone Marrow Stem Cell Transplant, Research ShowsDecember 6th, 2019- Heterogeneity of Human Bone Marrow and Blood Natural Killer Cells Defined by Single-Cell TranscriptomeSeptember 2nd, 2019
Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32August 7th, 2018
Grant Support
- University of Pennsylvania Patient-derived Xenograft Development and Trials CenterUNIVERSITY OF PENNSYLVANIA2023–2028
- University of Pennsylvania Patient-derived Xenograft Development and Trials CenterUNIVERSITY OF PENNSYLVANIA2023–2028
- Pathologic Signaling Pathways in AML CellsPHILADELPHIA VA MEDICAL CENTER2021–2024
